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human peripheral blood mononuclear cells is tested by flow
cytometry. The experimental details of nanoparticle administra-
tion to tumor-bearing mice, magnetic resonance imaging scanning
as well as subsequent tumor sample collection and their pro-
cessing for transmission electron microscopy, inductively coupled
plasma atomic emission spectroscopy, histological and immuno-
histochemical analyses are described. Biodistribution of the
nanoparticles in mice and blood serum analysis data for experi-
mental animals are given. The data are useful for an experiment
workflow design and for the development of theranostic systems
based on magnetic nanoparticles.
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 A comprehensive characterization of nanomaterial based on magnetic nanoparticles conjugated with pH-low-insertion
peptide is provided.
 The protocols used for in vitro and in vivo experiments are extensively described.
 These data are valuable for the design of nanomaterials for theranostics.1. Data
Thedataset in this articledescribes themethodof Fe3O4magneticnanoparticle (MNP) synthesis byco-
precipitation, its modification by 3-aminopropylsilane (APS) and conjugation with pH-(low)-insertion
peptide (pHLIP), the experimental details of the investigation ofMNP-pHLIP interactionwith cells invitro,
the experimental details of nanoparticles administration to tumor-bearing mice, magnetic resonance
imaging (MRI) scanning, tumor sample collection and their processing for TEM and for inductively
coupled plasma atomic emission spectroscopy, histological and immunohistochemical analyses. Fig. 1
describes the FTIR spectra of modified nanoparticles. Table 1 describes the elemental analysis data for
the modified nanoparticles. Fig. 2 describes the TGA data for the modified nanoparticles. Fig. 3 provides
the transmission electron microscopy (TEM) images of the modified nanoparticles. Fig. 4 provides the
scanning electronmicroscopy (SEM) images of MNP-APS andMNP-pHLIP. Fig. 5 and Table 2 describe the
data of dynamic light scattering (DLS) analysis for colloidal solutions of MNP-APS andMNP-pHLIP. Fig. 6
describes the effects ofMNP-pHLIPonbloodcell viability invitro. Fig. 7describes thedependenceof signal
intensity change in T2-weighted MR image on iron concentration in the tumor 40 hours after nano-
particles administration to mice. Fig. 8 provides Perls' Prussian blue stained sections of liver, spleen,
kidney, lung, right inguinal and intact lymph nodes of MDA-MB231 tumor-bearing mice administered
with MNP-pHLIP. Fig. 9 provides hematoxylin and eosin stained sections of thymus, liver, spleen, kidney
and lung of experimental animals. Table 3 describes the quantification of eosinophils in tumor micro-
section by TEM. Table 4 provides the data for iron concentration in the samples of tissue extracted from
experimental mice according to ICP-AES. Table 5 provides serum biochemical parameters of the exper-
imental mice.
2. Experimental design, materials, and methods
2.1. Synthesis of nanomaterials
Initial Fe3O4 magnetic nanoparticles were obtained by co-precipitation method [2,3]. The modifi-
cation of Fe3O4 nanoparticles with 3-aminopropylsilane was carried out according to Ref. [2] and with
pHLIP peptide according to Refs. [4,5] (Scheme 1). (3-Aminopropyl) trimethoxysilane (APTMS, 97%;
Alfa Aesar, England), 6-maleimidohexanoic acid N-hydroxysuccinimide ester (EMCS; Fluka, USA), pH-
low insertion peptide (NH2-ACEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT-COOH) (pHLIP; Bachem,
USA) were applied. All other chemicals of analytical grade were purchased from commercial suppliers
and used as received. Deionized (DI) water (18.2 M U cm1) and phosphate-buffered saline (PBS, pH
7.4) were used in the experiments.
Fig. 1. FTIR spectra of initial magnetic nanoparticles (MNP) (1), MNP-APS (2), MNP-EMCS (3), MNP-pHLIP (4), and pHLIP (5). The
characteristic absorption bands of MNP-APS (544 cm1, FeeO; 990 cm1, SieO) and the slightly shifted bands attributed to the
peptide (1632 cm1; C]O (amide I), 1530 cm1 CeN (amide II)), and the band at 1697 cm1 corresponding to the stretching vi-
brations of C]O of the cross-linker are presented on MNP-pHLIP FTIR spectrum.
Table 1
The elemental analysis data for MNP-APS, MNP-EMCS and MNP-pHLIP.
MNP-APS MNP-EMCS MNP-pHLIP
C, % 2.69 4.69 6.23
c, mmol/g MNPs 0.71/0.72a/0.68b 0.15 0.0035
a The amount of APS immobilized on the MNP surface calculated according to FTIR data.
b The amount of APS immobilized on the MNP surface calculated according to ICP-AES data.
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Amixture of FeSO4$7H2O (0.364 g, 1.31 mmol) and FeCl3$6H2O (0.714 g, 2.62 mmol) were dissolved
in 50 mL of water and heated to 40 C under argon flow. Then 3 mL of the saturated aqueous ammonia
solution was added to the resulting solution up to pH 11 under vigorous stirring. After 10 min the
resulting MNPs were precipitated by an external magnet, washed with DI water up to neutral pH and
resuspended in EtOH.
2.1.2. Preparation of APS-modified MNPs (MNP-APS)
A solution of APTMS (111.6 mL, 0.635 mmol) in EtOH (5 mL) was added to a solution of MNPs (0.210
g) in 50% EtOH (70 mL) under stirring and heated to 40 C for 8 h. The resulting MNP-APS were
precipitated by an external magnet, washed with EtOH and resuspended in MeCN.
2.1.3. EMCS-functionalization of MNP-APS (MNP-EMCS)
A solution of EMCS (15.8 mg, 0.051 mmol) in MeCN (3 mL) was added to a solution of MNP-APS (70
mg) in MeCN (35 mL), and the resulting mixture was stirred at room temperature for 3.5 h. The
resulting MNP-EMCS was centrifuged (18,000 rpm; 10 min), and subsequently washed with MeCN and
PBS.
Fig. 2. TGA data of MNP-APS (1), MNP-EMCS (2) and MNP-pHLIP (3). The total weight loss for samples 1e3, due to decomposition of
the organic shell, was 8.41, 14.29, 16.04 mg/g MNPs, respectively.
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The suspension of pHLIP (3.64 mg, 0.885 mmol) in PBS (3 mL) was added while stirring to a
dispersion of MNP-EMCS (50 mg) in PBS (30 mL) under argon flow to prevent disulfide pHLIP-
derivative formation. After 16 h, MNP-pHLIP was precipitated by an external magnet and washed
three times with PBS. The resulting materials were stored in PBS at 4 C.2.2. Characterization of MNP-pHLIP
2.2.1. FTIR analysis
IR spectra for nanopowders of synthesized materials were recorded on a Nicolet 6700 Thermo FTIR-
spectrometer by the attenuated total reflection (ATR) method on the diamond crystal, in the range of
4000e400 cm1 with 128 scans and at 4 cm1 resolution.
The immobilization of pHLIP on the APS-modified MNP surface through 6-maleimidohexanoic acid
N-hydroxysuccinimide ester was confirmed by FTIR spectroscopy (Fig. 1). The quantitative analysis of
3-aminopropylsilane content in MNP-APS was carried out in accordance with [6]. The FTIR spectra of
the analyzed samples were recorded in five replicates. The amount of APS (c) on MNP surface (mmol
per g of MNPs) was calculated according to the following formula:
c¼1:036 x1:279 (1)
where с is the amount of APS on the nanoparticle surface, mmol per 1 g of MNPs; x is the ratio of
integrated intensities of FeeO (in the range of 450e750 cm1) and SieO (in the range of 770e1160
cm1) absorption bands in the FTIR spectra.
2.2.2. ICP-AES analysis
The amount of APS in MNP-APS was calculated from the Si mass fraction, which was determined by
AES on an iCAP 6300 Duo ICP spectrometer (Thermo Scientific) using the intensity of themost sensitive
analytical spectral line at 251.6 nm. (Table 1).
2.2.3. Elemental analysis
The amount of pHLIP in the synthesized MNP-pHLIP was calculated from the elemental analysis
(CHN) data. The mass fraction of carbon was measured using a CHN РЕ 2400 II automatic analyzer
Fig. 4. SEM images of (A) MNP-APS and (B) MNP-pHLIP.
Fig. 3. TEM images of (A, B) MNP-APS and (C, D) MNP-pHLIP. (B) Region magnified from red square on A. (D) Region magnified from
red square on C. The parent MNP-APS particles were spherical or truncated polygonal in shape, varying from approximately 7 to 18
nm in size. The MNP-pHLIP represent nanoparticles surrounded by amorphous matrix.
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Fig. 5. Dynamic light scattering (DLS) size distributions (Dh) for (A) MNP-APS in water and (B) MNP-pHLIP in water and (C) MNP-
pHLIP in DMEM supplemented with 10% fetal bovine serum (FBS).
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Table 2
DLS analysis of MNP-APS and MNP-pHLIP.
Medium Types of size distribution Dh, nm zP, mV PdI Characters of size distribution
MNP-APS DI water by number 79 þ29.1 0.16 monomodal
by volume 91 monomodal
by intensity 109 monomodal
MNP-pHLIP DI water by number 142 22.1 0.10 monomodal
by volume 142 monomodal
by intensity 164 monomodal
MNP-pHLIP DMEM,10% FBS by number 142 9.6 0.19 monomodal
by volume 142 monomodal
by intensity 190 monomodal
Fig. 6. Effect of MNP-pHLIP on blood cells viability. The amount of (A) necrotic mouse peripheral blood mononuclear cells (PBMCs)
after incubation for 2 hours with MNP-pHLIP (20 mg [Fe]/mL), (B) necrotic human and (C) mouse monocytes after incubation for 24
hours with MNP-pHLIP (20 mg [Fe]/mL) according to 7-aminoactinomycin D (7-AAD) or SYTOX Green flow cytometry analysis. Data
are shown as the mean ± SD.
Fig. 7. The dependence of SI changes in T2-weighed MR images on iron concentration in the tumors (A) in group of mice admin-
istered with MNP-pHLIP, (B) in two groups of mice administered with MNP-APS and MNP-pHLIP.
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calculated in accordance with method described in Refs. [4,7].
Thermogravimetric analysis. Thermogravimetric analysis (TGA) was carried out on a TGA/DSC1
instrument (Mettler Toledo) with a heating rate of 10 C min1 and a temperature range of 30e900 C
under compressed Ar (Fig. 2).
2.2.4. TEM
For the analysis of MNP-APS and MNP-pHLIP a drop of nanoparticle suspension was placed onto
formvar-coated copper grids. The excess liquid was then removed by filter paper and the sample was
left to dry under ambient air, before being analyzed under the transmission electron microscope JEM-
Fig. 8. Histological examination of (A) right inguinal lymph node with perinodal adipose tissue, (B) liver, (C) spleen, (D) kidney (E)
lung and (F) intact lymph node of MDA-MB231 tumor-bearing mice extracted 40 h after MNP-pHLIP administration. Perls' positive
cells was identified in metastasis in the regional lymph node isolated from one mouse injected with MNP-pHLIP. Notably, hardly any
Perls' positive cells were found in the liver. Perls' positive cells are identified in splenic macrophages. Perls' Prussian blue staining,
shown at a  400 magnification.
A.G. Pershina et al. / Data in brief 29 (2020) 105062 91400 (JEOL, Tokyo, Japan) (Fig. 3). In the case of MNP-pHLIP nanoparticles, the samples were prelim-
inarily stained with uranyl acetate and lead citrate.
2.2.5. SEM
Nanoparticles were characterized using Merlin scanning electron microscope (Carl Zeiss, Germany)
equipped with Gemini columnwith Schottky field emission cathode as an electron source. The average
diameter of MNP-APS and MNP-pHLIP were 11 and 13 nm respectively (Fig. 4).
2.2.6. DLS
Dynamic light scattering and zeta potential (zP) characterization were carried out using Malvern
Zetasizer Nano ZS. Average hydrodynamic diameter (Dh) of MNP-APS and MNP-pHLIP was measured
by the three different types of size distributions generated by DLS (number-, volume-, and intensity-
weighted distribution) for their colloidal solutions (250 mg/L) in DI water and DMEM with 10% fetal
bovine serum (Fig. 5, Table 2).2.3. In vitro experiments
2.3.1. Interaction of MNP-pHLIP with MDA-MB231 cells
The MDA-MB231 cells (human adenocarcinoma, ATCC) were grown in 5% CO2 at 37 C in complete
DMEM/F-12 (HyClone) medium supplemented with 10% (vol/vol) fetal bovine serum (FBS, Biosera), L-
glutamine and gentamicin.
For the cytotoxicity assay MNP-pHLIP in PBS was added to 105 adheredMDA-MB231 cells in 24-well
plate (1:10 vol/vol) to a final concentration of 4e40 mg [Fe]/mL and incubated for 2, 24 and 48 h. In
control wells, an equal volume of PBS instead of MNP-pHLIP was added. After that, cells were washed
twice with PBS, detached by TrypLE without phenol red (Thermo Fisher Scientific), centrifuged for 7
Fig. 9. Histological examination of (A) the thymus (B) liver, (C) spleen, (D) kidney, (E) lung of MDA-MB231 tumor-bearing mice
extracted 40 h after PBS, MNP-APS or MNP-pHLIP administration. Hematoxylin & eosin staining, shown at a  400
magnification.
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Table 3
Quantification of eosinophils in tumor microsection by TEM.
Control MNP-APS MNP-pHLIP
# of sample 1 2 3 1 2 3 1 2 3 4
N (cell) 50 50 50 50 50 50 50 50 50 50
N (eosinophil) 0 0 0 2 5 1 5 1 1 0
Eosinophils, % 0.00 0.000 0.00 4.00 10.00 2.00 10.00 2.00 2.00 0.00
Table 4
Concentration of Fe (mg/g) in the samples of tissue extracted from PBS, MNP-APS and MNP-pHLIP administered mice according
to ICP-AES data.
Tissue type Control n ¼ 9 MNP-APS n ¼ 9 MNP-pHLIP n ¼ 9
mean SD mean SD mean SD
Kidney 0.13 0.02 0.13 0.04 0.15 0.05
Spleen 0.98 0.40 1.14 0.31 1.28 0.38
Liver 0.26 0.03 0.23 0.04 0.23 0.03
Lung 0.22 0.04 0.21 0.07 0.20 0.05
Thymus 0.18 0.08 0.21 0.11 0.16 0.07
Table 5
Serum analysis of the MDA-MB231 tumor-bearing mice 40 h after PBS (control), MNP-APS and MNP-pHLIP administration.
Parameter Control n ¼ 9 MNP-APS n ¼ 9 MNP-pHLIP n ¼ 9
mean SE mean SE mean SE
ALT, U/L 74.78 16.33 75.67 13.14 66.00 12.19
AST, U/L 119.00 10.81 139.20 12.57 146.10 11.92
Urea, U/L 8.08 0.39 8.32 0.37 9.00 0.48
Creatinine, umol/L 30.35 0.83 29.38 0.49 29.51 0.55
Albumin, g/L 31.25 0.31 31.56 0.47 32.33 0.78
AbbreviationsALT, Alanine transaminase; AST, Aspartate aminotransferase; ALP, Alkaline phosphatase.
Scheme 1. Immobilization of pHLIP on MNP surface.
A.G. Pershina et al. / Data in brief 29 (2020) 105062 11min at 2000 rpm (MiniSpin, Eppendorf), and suspended in 200 mL of PBS. Cell viability was measured
using 7-aminoactinomycin D (7-aad, Biolegend, San Diego, CA) according to the manufacturer's pro-
tocol on a BD Accuri-C6 flow cytometer. 7-AAD was dissolved in 1 mL of DMSO. For analysis, 2 mL of 7-
AAD solution was added to 105 cells in PBS buffer.
The ability of MNP-pHLIP to bind MDA-MB231 in a pH-dependent manner was analyzed at pH 6.8
and 7.4. The pH 6.8 medium was prepared by addition of 1 M HEPES, pH 5.6 (Sigma) up to a con-
centration of 50 mM. MNP-pHLIP in PBS was added to 105 MDA-MB231 cells seeded in 24-well plate
(1:10 vol/vol) to a final concentration of 4e20 mg [Fe]/mL and incubated at pH 6.8 or 7.4. After 1 h, cells
A.G. Pershina et al. / Data in brief 29 (2020) 10506212were washed twice with PBS (pH 6.8/7.4), detached by TrypLE without phenol red (Thermo Fisher
Scientific), centrifuged for 7 min at 2000 rpm, and suspended in 200 mL of PBS (pH 6.8/7.4). 50 mL of cell
suspension was used for cell counting on BD Accuri C6.
The 150 mL of cell suspensionwas evaporated, lysed in 80 mL of HCl overnight, and then 520 mL of DI
H2O was added. The iron concentration was determined using a slightly modified colorimetric
ferrozine-based assay [8]. For ferrozine test preparation 1.9 g ammonium acetate (AppliChem), 16 mg
ferrozine iron reagent (Acros organics), 1.8 g L-ascorbic acid (Carl Roth GmbH þ Co. KG), 13.5 mg
neocuproine (Aldrich) were dissolved in 5 mL of DI water. 600 mL of samples were mixed with 60 mL of
the ferrozine test solution, transferred to a 96-well plate, and the optical density was measured at 570
nm on a microplate reader (Sunrise, Tecan). FeCl3 (Sigma Aldrich) water solution (0.1e2.0 mg/mL) was
used for the calibration curve.
For Perls’ staining,106 cells were seeded in a 6-well plate and incubatedwith nanoparticles in a final
concentration of 10 mg [Fe]/mL in a complete DMEM/F-12 medium at pH 6.8 and 7.4, respectively. After
incubation, cells were washed 3 times with PBS (pH 6.8/7.4) and fixed in 4% paraformaldehyde in PBS
buffer for 30 min, washed 3 times with DI water, and stained with 4% K4 [Fe(CN)6] in 4% HCl. The cell
nucleus was counterstained by 0.5% neutral red (Sigma-Aldrich) prepared in a sodium acetate buffer
(pH 4.8).
2.3.2. Effect of MNP-pHLIP on mouse PBMCs viability
Mouse peripheral blood mononuclear cells (PBMCs) were isolated from BALB/c mouse blood
(heparinized) obtained by cardiac puncture. Blood was diluted with HBSS 1:2, layered over Ficoll
density gradient (PanEco), centrifuged at 400g for 30 min, washed twice with HBSS (Gibco) at 300g for
10 min, and resuspended in RPMI (PanEco). 105 PBMCs were mixed with MNP-pHLIP (to final con-
centration 20 mg [Fe]/mL) in a polypropylene tube and incubated for 2 h at 37 C on rotator. After this,
cells were washed twice with HBSS via centrifugation and resuspended in PBS buffer. Cell viability was
measured using 7-aad (Fig. 6A).
2.3.3. Effect of MNP-pHLIP on viability of human/mouse monocytes
Human PBMCs were obtained from the blood of healthy donors using Ficoll (PanEco) density
gradient centrifugation at 500g for 30 min, washed twice with HBSS (Gibco) by centrifugation at 165g
for 20 min and resuspended in RPMI. Monocytes were isolated from human or mouse PBMCs similarly
using Percoll (GE Healthcare Bio-Sciences AB) double density gradient centrifugation at 2058g for 50
minutes at 20 C, washed twice with HBSS (Gibco) by centrifugation at 659g for 15 min and resus-
pended in RPMI.
The purified human/mouse monocytes were then seeded in 24-well plates at a concentration of
105 cells per well in RPMI 1640medium supplementedwith 10% (vol/vol) fetal bovine serum (complete
RPMI), L-glutamine, 2-mercaptoethanol and penicillin-streptomycin. 24 h after cell incubation at 37 C
in 5% CO2, the mediumwas replaced with 450 mL of fresh complete RPMI medium. A suspension of the
MNP-pHLIP was then added to cells (1:10 vol/vol) to a final concentration equal to 20 mg [Fe]/mL; cells
were incubated for 24 hours at 37 C in 5% CO2. In control wells, equal volumes of PBS instead MNP-
pHLIP were added. Cell viability was measured using membrane-impermeant DNA-binding fluores-
cent dyes: 7-aad (for mouse monocytes) and SYTOX green (Thermo Fisher Scientific) (for human
monocytes) (Fig. 6B and C).
2.4. Animal experiments
The animal experiments were conducted in compliance with the Guide for the Care and Use of
Laboratory Animal Resources (1996) and approved by the Bioethics Review Committee of the Institute
of Cytology and Genetics SB RAS (No. 38 from July 18, 2017).
To establish xenografts, 4e6 week old female SCID (SHO-PrkdcscidHrhr) mice (n ¼ 27) were
injected in the right fat pad with 5*106 MDA-MB231 cells suspended in 100 mL of serum free media and
matrigel at a 1:1 ratio. The mice were housed in individually ventilated OptiMICE cages (Animal Care
Systems) in groups of three animals per cage with ad libitum food (Ssniff) and water. The cages con-
taining the mice were held in a barrier room of SPF animal facility with a regular 14/10 h light/dark
A.G. Pershina et al. / Data in brief 29 (2020) 105062 13cycle (lights on 02:00AM), a constant room temperature of 24 C ± 2 C, and a relative humidity of
approximately 45% ± 15%. Tumors were developed for 6 or 8 weeks, with varying volumes at the end of
this period.
Suspensions of MNP-APS and MNP-pHLIP in PBS buffer (100 mL) were administered to mice by
retro-orbital (venous sinus) route in a dose of 1 mg [Fe]/kg. Before administration, the suspensions
were sonicated using Q700 Sonicator equipment with cup horn (Qsonica L.L.C, Newtown, CT, USA). The
tumor-bearing mice administered 100 mL PBS were used as control. Before and 40 h after nanoparticle
administration, the mice were MRI scanned.
2.4.1. 1Н MRI
The 1Н MRI experiment was performed on a horizontal tomographic scanner with magnetic field
intensity of 11.7 T (Bruker, Biospec 117/16 USR). The mice were anesthetized with gas anesthesia
(Isofluran; Baxter Healthcare Corp., Deerfield, IL) using a Univentor 400 Anesthesia Unit (Univentor,
Zejtun). The animal body temperature was maintained with a water circuit installed into the table bed
of the tomographic scanner, which maintained the temperature of 30 C on its surface. A pneumatic
respiration sensor (SA Instruments, Stony Brook, NY) was placed under the lower body part, which
allowed control of anesthesia depth. MR images were recorded with a receiveretransmitter 1H volume
coil (T11440V3). High-resolution T2-weighted images of tumors in themice (section thickness 0.5 mm;
field of vision (FOV) 4.0  4.0 mm; matrix 512  512 dots) were acquired with respiratory triggering
using TurboRARE T2 (Rapid Acquisition with Relaxation Enhancement) method with pulse sequence
parameters: TEeff ¼ 11 ms, TR¼ 2500 ms, Flip Angle¼ 180, RARE Factor¼ 42. Signal intensity (SI) was
measured within the region of interest (ROI) in the tumor and standard phantom. The SI changes in T2-
weighted MR images of the tumor recorded before and 40h after MNP-APS and MNP-pHLIP admin-












where T2 - is the ratio of the SI change in T2-weighted MR image of tumor before and 40h after
nanoparticle administration, %
SITpost- SI measured within the ROI in the tumor 40h after nanoparticle administration;
SIPpost - SI measured within the ROI in standard phantom 40h after nanoparticle administration;
SITpre - SI measured within the ROI in the tumor before nanoparticle administration;
SIPpre - SI measured within the ROI in standard phantom before nanoparticle administration.
2.4.2. Biological sample collection
After MRI scanning, anesthetized mice were sacrificed by cervical dislocation. Blood samples were
collected in Microvette® CB 300.
The liver, spleen, kidney, lung, thymus, intact and regional lymph nodes, and tumors were dissected
and weighed. The organs (50e60 mg) and tumor samples (10e50 mg) were frozen at 80 C for iron
content determination. Samples of tumors (with small, medium, and large volume extracted from
randomly chosen mice in control (n¼ 3), MNP-APS (n¼ 3) and MNP-pHLIP (n¼ 4) groups) were taken
for TEM and histological examination. For this purpose, a small piece (1 mm3) of tumor was imme-
diately placed in cold 2.5% glutaraldehyde in 0.1 M Na cacodylate buffer (7.4) for TEM analysis. Another
piece of the sample was placed into 10% neutral buffered formalin for histological analysis.
2.4.3. Transmission electron microscopy
Fixation for TEM analysis was carried out according to Ref. [9]. Tumor samples were fixed in 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, for 2e3 h, followed by 3 washes in the same
buffer for 5 min each. Then the samples were post-fixed with 1% OsO4 and 0.8% potassium ferrocyanide
in cacodylate buffer for 1 h, rinsed 3 times in distilledwater and left in 1% aqueous uranyl acetate at 4 C
for 12 h. Samples were dehydrated in ethanol series (30%, 50%, 70%, 96% and 100% for 10 min each) and
acetone (twice, for 20 min), embedded in Agar 100 Resin (Agar Scientific Ltd., Essex, UK), and left to
polymerize at þ60С for 2e3 days. Semi-thin sections were obtained with a ReicherteJung ultracut
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Аxioscop 40 (Zeiss, Jena, Germany) light microscope. Ultrathin sections were made using a Leica
ultracut ultra-microtome (Leica, Wetzlar, Germany) and examined with a transmission electron mi-
croscope JEM-1400 (JEOL, Tokyo, Japan). For the evaluation of eosinophils inside tumor tissue, random
ultrathin sections of each sample were taken and the percentage of eosinophils among random cells
(n ¼ 50 per sample) was counted (Table 3).
2.4.4. ICP-AES
Tissue samples were digested in 3 mL of nitric acid and boiled until the formation of a colorless
solution. The solution volume was then brought up to 10 mL by DI water and the concentration of Fe
was measured by inductively coupled plasma atomic emission spectroscopy (iCAP 6300 Duo, Thermo
Scientific) (Table 4). Fig. 7 shows the dependence of SI change in T2-weighed MR image of tumor after
nanoparticle administration on iron concentration in the tumors determined according to ICP-AES.
2.4.5. Histological analysis
For histological analysis, samples were processed on the Excelsior™ AS Tissue Processor (Thermo
Scientific): samples were dehydrated in isopropanol series and embedded in HISTOMIX paraffin
(Biovitrum). Tissue sections were cut into 4-5 mm-thick slices (HM 325 Rotary Microtome, Thermo
Scientific). The histological slides were analyzed via optical microscope Axioskop 40 FL (Carl Zeiss)
(Figs. 8 and 9). Standard hematoxylin and eosin, Perls' Prussian blue and Van Gieson's (using combined
solutions of picric acid and acid fuchsin) staining protocols were used for standard analysis, iron ag-
gregates and collagen fiber visualization.
2.4.6. Immunohistochemical analysis of tumor
Formalin-fixed, paraffin-embedded tissue sections were deparaffinized by washing in two changes
of xylene, then dehydrated in 100%, 95% and 70% ethanol followed by water. EDTA (pH 8.8) antigen
retrieval buffer was used to unmask the antigenic epitope. Immunohistochemical staining of tumor
sections was performed on BOND-MAX Automated IHC/ISH Stainer (Leica Biosystems) using anti-CD31
primary antibody (1:20, ab28364, Abcam) and EnVision FLEX/HRP (Dako). The slides were developed
with EnVision FLEX DAB þ CHROMOGEN (EnVision FLEX Substrate Buffer, Dako).
2.4.7. Serum analysis
Mouse serum was analyzed on ARCHITECT c4000 (Abbott Diagnostics, Lake Forest, IL) using com-
mercial kits (DiaS) (Table 5).
2.5. Statistical analysis
Statistical analyses were performed using a statistics program (GraphPad Prism; GraphPad Soft-
ware). Data are presented as mean (SD). The data were tested by the ShapiroeWilk test for normality.
The differences between continuous variables with normal distributionwere analyzed by the Student's
t-test. When three groups were compared the differences among continuous variables with normal
distribution were analyzed by the ANOVA, and among continuous variables with non-normal distri-
bution by the Kruskal-Wallis test. A p value below 0.05 was considered as significant.
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